(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1602686 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CLMP mRNA CTD PMID:22079256 (S)-nicotine increases expression ISO RGD:1602686 6480464 Nicotine results in increased expression of CLMP mRNA CTD PMID:23825647 17alpha-ethynylestradiol decreases expression ISO RGD:708569 6480464 Ethinyl Estradiol results in decreased expression of CLMP mRNA CTD PMID:17557909 17beta-estradiol affects expression ISO RGD:1602686 6480464 Estradiol affects the expression of CLMP mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1602686 6480464 Estradiol results in increased expression of CLMP mRNA CTD PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1602686 6480464 Tetrachlorodibenzodioxin results in increased expression of CLMP mRNA CTD PMID:20106945 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:708569 6480464 Tetrachlorodibenzodioxin affects the expression of CLMP mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:708569 6480464 Tetrachlorodibenzodioxin results in increased expression of CLMP mRNA CTD PMID:26232522 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1602686 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLMP mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO RGD:1602686 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of CLMP mRNA CTD PMID:30616060 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of CLMP mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO RGD:708569 6480464 Propylthiouracil results in increased expression of CLMP mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:708569 6480464 acetamide results in increased expression of CLMP mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1602686 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CLMP mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CLMP mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CLMP mRNA CTD PMID:30807115 aflatoxin B1 affects expression ISO RGD:1602686 6480464 Aflatoxin B1 affects the expression of CLMP protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1602686 6480464 Aflatoxin B1 results in increased methylation of CLMP intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:1602686 6480464 Aflatoxin B1 results in increased expression of CLMP mRNA CTD PMID:22100608 , PMID:32234424 alpha-pinene multiple interactions ISO RGD:1602686 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CLMP mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CLMP mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:708569 6480464 Ammonium Chloride affects the expression of CLMP mRNA CTD PMID:16483693 benzo[a]pyrene increases expression ISO RGD:1602686 6480464 Benzo(a)pyrene results in increased expression of CLMP mRNA CTD PMID:20106945 benzo[a]pyrene decreases methylation ISO RGD:1602686 6480464 Benzo(a)pyrene results in decreased methylation of CLMP 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:708569 6480464 Benzo(a)pyrene results in increased expression of CLMP mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1602686 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CLMP mRNA CTD PMID:25270620 bisphenol A decreases methylation ISO RGD:1602686 6480464 bisphenol A results in decreased methylation of CLMP gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1602686 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLMP mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:708569 6480464 bisphenol A results in decreased expression of CLMP mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases expression ISO RGD:708569 6480464 bisphenol A results in increased expression of CLMP mRNA CTD PMID:25181051 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1602686 6480464 CGP 52608 promotes the reaction [RORA protein binds to CLMP gene] CTD PMID:28238834 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of CLMP mRNA CTD PMID:33711761 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of CLMP mRNA CTD PMID:23125180 chromium(6+) decreases expression ISO RGD:1602686 6480464 chromium hexavalent ion results in decreased expression of CLMP mRNA CTD PMID:30690063 copper atom increases expression ISO RGD:708569 6480464 Copper results in increased expression of CLMP mRNA CTD PMID:30556269 copper(0) increases expression ISO RGD:708569 6480464 Copper results in increased expression of CLMP mRNA CTD PMID:30556269 Cuprizon decreases expression ISO RGD:708569 6480464 Cuprizone results in decreased expression of CLMP mRNA CTD PMID:26577399 dexamethasone multiple interactions ISO RGD:1602686 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLMP mRNA CTD PMID:28628672 diallyl trisulfide increases expression ISO RGD:1602686 6480464 diallyl trisulfide results in increased expression of CLMP mRNA CTD PMID:34995734 diuron decreases expression ISO RGD:708569 6480464 Diuron results in decreased expression of CLMP mRNA CTD PMID:25152437 diuron increases expression ISO RGD:708569 6480464 Diuron results in increased expression of CLMP mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:1602686 6480464 Doxorubicin results in decreased expression of CLMP mRNA CTD PMID:29803840 hydrogen peroxide affects expression ISO RGD:1602686 6480464 Hydrogen Peroxide affects the expression of CLMP mRNA CTD PMID:20044591 hydroquinone increases expression ISO RGD:1602686 6480464 hydroquinone results in increased expression of CLMP mRNA CTD PMID:31256213 indometacin multiple interactions ISO RGD:1602686 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLMP mRNA CTD PMID:28628672 ketamine decreases expression ISO RGD:708569 6480464 Ketamine results in decreased expression of CLMP mRNA CTD PMID:20080153 kojic acid decreases expression ISO RGD:1602686 6480464 kojic acid results in decreased expression of CLMP mRNA CTD PMID:16595896 lipopolysaccharide multiple interactions ISO RGD:1602686 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CLMP mRNA CTD PMID:35811015 maneb multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in decreased expression of CLMP mRNA CTD PMID:36117858 methoxychlor affects methylation ISO RGD:708569 6480464 Methoxychlor affects the methylation of CLMP gene CTD PMID:35440735 N,N-diethyl-m-toluamide multiple interactions ISO RGD:708569 6480464 [Permethrin co-treated with DEET] results in decreased methylation of CLMP gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression ISO RGD:1602686 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CLMP mRNA CTD PMID:24810058 N-Nitrosopyrrolidine increases expression ISO RGD:1602686 6480464 N-Nitrosopyrrolidine results in increased expression of CLMP mRNA CTD PMID:32234424 nickel atom decreases expression ISO RGD:1602686 6480464 Nickel results in decreased expression of CLMP mRNA CTD PMID:25583101 nicotine increases expression ISO RGD:1602686 6480464 Nicotine results in increased expression of CLMP mRNA CTD PMID:23825647 oxaliplatin multiple interactions ISO RGD:708569 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CLMP mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:708569 6480464 oxaliplatin results in increased expression of CLMP mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1602686 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CLMP mRNA more ... CTD PMID:32699268 paraquat increases expression ISO RGD:708569 6480464 Paraquat results in increased expression of CLMP mRNA CTD PMID:32680482 paraquat multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in decreased expression of CLMP mRNA CTD PMID:36117858 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 permethrin multiple interactions ISO RGD:708569 6480464 [Permethrin co-treated with DEET] results in decreased methylation of CLMP gene CTD PMID:33148267 potassium chromate multiple interactions ISO RGD:1602686 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CLMP mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1602686 6480464 potassium chromate(VI) results in decreased expression of CLMP mRNA CTD PMID:22079256 , PMID:22714537 propanal increases expression ISO RGD:1602686 6480464 propionaldehyde results in increased expression of CLMP mRNA CTD PMID:26079696 rotenone decreases expression ISO RGD:708569 6480464 Rotenone results in decreased expression of CLMP mRNA CTD PMID:19013527 , PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1602686 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of CLMP mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1602686 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CLMP mRNA CTD PMID:35811015 silicon dioxide increases expression ISO RGD:1602686 6480464 Silicon Dioxide analog results in increased expression of CLMP mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CLMP mRNA CTD PMID:29341224 Soman decreases expression ISO RGD:708569 6480464 Soman results in decreased expression of CLMP mRNA CTD PMID:19281266 temozolomide decreases expression ISO RGD:1602686 6480464 Temozolomide results in decreased expression of CLMP mRNA CTD PMID:31758290 testosterone decreases expression ISO RGD:1602686 6480464 Testosterone results in decreased expression of CLMP mRNA CTD PMID:33359661 tetraphene decreases expression EXP 6480464 benz(a)anthracene results in decreased expression of CLMP mRNA CTD PMID:26377693 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CLMP mRNA CTD PMID:23557971 , PMID:27760801 topotecan multiple interactions ISO RGD:708569 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CLMP mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:708569 6480464 Topotecan results in increased expression of CLMP mRNA CTD PMID:25729387 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of CLMP mRNA CTD PMID:29279043 valproic acid decreases expression ISO RGD:1602686 6480464 Valproic Acid results in decreased expression of CLMP mRNA CTD PMID:19101580 , PMID:28001369 valproic acid affects expression ISO RGD:1602686 6480464 Valproic Acid affects the expression of CLMP mRNA CTD PMID:25979313 vinclozolin increases expression ISO RGD:708569 6480464 vinclozolin results in increased expression of CLMP mRNA CTD PMID:22570695 vinclozolin increases methylation ISO RGD:708569 6480464 vinclozolin results in increased methylation of CLMP gene CTD PMID:30207508
